According to the report, the global electronic clinical outcome assessment (eCOA) market was valued at approximately USD 618 million in 2017 and is expected to generate revenue of around USD 1,822 million by 2024, growing at a CAGR of around 16.7% between 2018 and 2024.
Electronic Clinical Outcome Assessments (eCOAs) determine a patient’s condition as along with the effects and progression of a disease. The eCOAs provide real-time visibility that helps in improving the adherence to protocol execution, ensuring patient safety and engagement, and reducing trial risks. The growing penetration of advanced technologies, the rising adoption of software solutions during research studies, government initiatives to support clinical trials, and huge R&D expenditure by pharmaceutical companies are some key factors fueling the electronic clinical outcome assessment (eCOA) market over the forecast time period. However, the high implementation cost might hinder the future of electronic clinical outcome assessment (eCOA) market.
Request Free Sample Report of Electronic Clinical Outcome
Assessment (eCOA) Market Report @ https://goo.gl/F29F4E
Facebook Comments